Exclusive Biotech Intelligence for the Big4Bio Community
Accessing reliable, real-time data on private biotech companies by combining funding and clinical trial insights in one easy-to-use platform. Save time, uncover opportunities early, and make informed decisions—at a fraction of the price, as a Big4Bio member.
A Single Platform for Private Biotech & VC Intelligence
Exclusive Pricing for Big4Bio Subscribers — Just $1,198/Year (Regular Rate: $2,500)
With a BYTE51 subscription you can:
- Gain access to $670 billion of life science VC funding and clinical data on 12,000 investors and 14,500 private biotech companies
- Combine VC funding data with clinical stage data for data-driven decisions
- Customize and save your search filters and receive notifications daily
- Receive weekly emails of new Series A, B, and C companies to identify prospects in real-time
- Get unlimited access to the tools you need to identify opportunities, assess risks, and make informed decisions with confidence
Providing science and funding data for:
- Private Equity
- Biotech Companies
- Commercial Banks
- Investment Banks
- Asset Management Firms
- Law Firms
- Real Estate Firms
- Pharmaceutical
- HC Companies
- Start ups
- Venture Capital
- Consulting Firms
- Registered Investment Advisors
- Family Offices
- Academic
Get Full Access to BYTE51 at More Than 50% Off
BYTE51 was built for professionals who need reliable, up-to-date biotech data without the complexity. While others pay up to $20,000 a year for similar insights, Big4Bio members get full access for less than the cost of a cup of coffee a day.
Want to See BYTE51 in Action?
In just 30 minutes, explore how BYTE51 simplifies biotech data and helps you find the insights that matter most. No pressure, just a chance to see if it’s a fit for your needs